Cancer Treatment Centers of America - Atlanta, Atlanta
Emory University Winship Cancer Institute, Atlanta
Gynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research Pavilion, Savannah
ir dar 3

Renkami dalyviai2 fazė

Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT02693535

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Winship Cancer Institute of Emory University, Atlanta

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT04879043

Collection of Tissue Samples for Cancer Research

Emory University, Atlanta

Renkami dalyviaiStebimasis tyrimas

2 Months · Visoms lytims · Atnaujinta 2026-09-16 · NCT00900198

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Winship Cancer Institute, Emory University, Atlanta

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Winship Cancer Institute of Emory University, Atlanta
Northside Hospital, Atlanta

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT06297226

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

Emory University Hospital Midtown, Atlanta

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT07555938

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

Emory University/Winship Cancer Institute, Atlanta

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT05208307

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Emory University Hospital, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07075185

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Research Site, Atlanta

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT07681596

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

GSK Investigational Site, Macon

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07227311

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Research Site, Atlanta

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT06106945

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

The Winship Cancer Institute of Emory University, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Research Site, Atlanta

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT05850234

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Research Site, Atlanta

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

Winship Cancer Institute, Emory University, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-12 · NCT07280013

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Winship Cancer Institute, Emory University, Atlanta

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT07284758

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute, Atlanta

Renkami dalyviai4 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-23 · NCT07101445

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Winship Cancer Institute of Emory University /ID# 274830, Atlanta

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-21 · NCT06892522

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Northside Hospital, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-16 · NCT06121843

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Winship Cancer Institute of Emory University, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-08 · NCT05137054

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Emory Winship Cancer Institute, Atlanta

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-24 · NCT04068597

Personalized Autologous Transplant for Multiple Myeloma

Winship Cancer Institute of Emory University, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-15 · NCT04483206

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

Emory University Hospital/Winship Cancer Institute, Atlanta

Renkami dalyviai

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-05 · NCT03858205

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Emory University Hospital, Atlanta

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-04 · NCT05243797

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Emory Winchip Cancer Center, Atlanta

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-19 · NCT06433947

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

GSK Investigational Site, Atlanta

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-22 · NCT06679101

CAR T-cell Therapy in Patients With Renal Dysfunction

Caitlin Guzowski, Atlanta

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-20 · NCT05909059

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.